Bladder cancer survivors and local health leaders are rallying the Cincinnati community for the city’s first Walk to End ...
When the bladder is surgically removed (an operation called radical cystectomy) to treat bladder cancer, surgeons also remove nearby lymph nodes, small glands that are part of the immune system. This ...
Bladder cancer arises from the lining of the bladder, the organ that stores urine, and is one of the most common cancers in the United States. Most patients are diagnosed at an early stage called ...
Bladder cancer arises from the lining of the bladder, the organ that stores urine, and is one of the most common cancers in the United States. Most patients are diagnosed at an early stage called ...
Patients with Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer in Europe may soon have a new bladder-sparing treatment option after the European Medicines Agency’s ...
NCCN 2026 Bladder Cancer Guidelines Adopt IBCG Risk Stratification Model for Intermediate-Risk NMIBC
The 2026 NCCN Bladder Cancer Guidelines incorporate the IBCG five-factor model, introducing standardized risk stratification for intermediate-risk NMIBC. For decades, heterogeneity in ...
Source: Getty Images A growing body of research seeks to validate ctDNA as a means of guiding MIBC treatment, particularly immunotherapy. Serial testing of circulating tumor DNA (ctDNA) — a fraction ...
A phase III randomised control clinical trial of radiotherapy with radiosensitisation versus intravesical bacillus Calmette-Guerin therapy for high-risk non-muscle invasive bladder cancer: TRAIN.
At first glance, the findings appear encouraging: CREST and POTOMAC demonstrated modest but statistically significant improvements in event-free survival (EFS) and disease-free survival (DFS), ...
Please provide your email address to receive an email when new articles are posted on . Neoadjuvant and adjuvant pembrolizumab plus enfortumab vedotin significantly benefited patients with ...
A permanent J code helps standardize billing and clarifies expected payment levels, often embedding reimbursement terms into payer contracts. In this video, Jonathan Rubenstein, MD, a urologist with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results